PennyMac Mortgage Investment Tr

What they do

PMT is a REIT that primarily invests in mortgage loans, mortgage-backed securities, and mortgage servicing rights. It operates through correspondent production (acquiring loans from other lenders) and credit sensitive strategies (investing in non-Agency subordinate bonds and other credit-sensitive mortgage assets). The company also invests in Agency-eligible loans and MBS, and manages a portfolio of MSRs.

Revenue drivers

• Credit sensitive strategies — Investments in non-Agency subordinate bonds and other credit-sensitive assets; in Q2 2026, generated $120 million of net new investments in non-Agency subordinate bonds.
• Correspondent production — Acquired $2.6 billion UPB of loans in Q2 2026, down 8% from prior quarter; beginning June 2026, stopped acquiring Agency-eligible conventional loans but continues acquiring non-Agency loans.
• Mortgage servicing rights (MSRs) — Holds a portfolio of MSRs; in Q2 2026, agreed to sell $13 billion UPB of low-coupon Agency MSRs, reducing exposure.
• Agency-eligible and jumbo securitizations — Closed six securitizations totaling $2.2 billion UPB in Q2 2026; generated $36 million in net new investments in non-Agency subordinate bonds from post-quarter deals.

Recent performance

For Q2 2026, PMT reported net income attributable to common shareholders of $20 million, or $0.23 per diluted share, on net investment income of $73 million, compared to a net loss of $(3) million in Q2 2025. Annualized return on common equity was 6% for the quarter. Book value per share was $14.83 at quarter end, down from $14.98 in Q1 2026. Quarterly revenue has declined from $99.2 million in Q3 2025 to $72.7 million in Q2 2026. Dividends declared remained stable at $0.40 per common share quarterly.

Strategy

Management is shifting equity allocation toward credit-sensitive strategies, which they see as more accretive, citing return potential in the low-to-mid teens. They are reducing MSR exposure, including the sale of $13 billion UPB of MSRs and stopping Agency-eligible loan acquisitions in correspondent production. The proceeds are being redeployed into organically-created credit investments, particularly non-Agency subordinate bonds, through the private label securitization program.

Risks

• Interest rate fluctuations — Changes in interest rates can significantly decrease results of operations, cash flows, and fair value of investments.
• Macroeconomic and housing market conditions — Deterioration in real estate, mortgage, or financial conditions could adversely affect the business; rising homeownership costs may increase delinquencies and defaults.
• Substantial indebtedness — PMT has a large debt burden ($1.56B in long-term debt as of 2030-09-30) that could limit financial flexibility and increase costs due to rate fluctuations.
• Regulatory and licensing requirements — Failure to maintain Agency approvals or state licenses could materially impact operations and financial condition.

Outlook

Management expects the realignment of the balance sheet to bolster return profile, with credit investments offering low-to-mid teens return potential. The company anticipates completing the MSR sale at the end of August 2026 and continues to execute private label securitizations, with post-quarter capital deployment of $36 million in non-Agency subordinate bonds. However, the stop in Agency-eligible loan acquisitions will reduce correspondent production volumes going forward.